Microbot Medical adds Sanmina manufacturing capacity for LIBERTY
Microbot Medical signed a letter of agreement with Sanmina to manufacture the FDA-cleared LIBERTY Endovascular Robotic System.
Evidence notes
- Microbot framed the Sanmina agreement as a second manufacturing site and capacity expansion.
- LIBERTY is an FDA-cleared, single-use robotic system for remote endovascular procedures.
Company context
Microbot Medical develops LIBERTY, a compact single-use endovascular robotic system designed for remotely operated vascular access and navigation.